Literature DB >> 20122939

Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.

Sharon J Schultz1, Miaohua Zhang, James J Champoux.   

Abstract

The RNase H activity of reverse transcriptase is required during retroviral replication and represents a potential target in antiviral drug therapies. Sequence features flanking a cleavage site influence the three types of retroviral RNase H activity: internal, DNA 3'-end-directed, and RNA 5'-end-directed. Using the reverse transcriptases of HIV-1 (human immunodeficiency virus type 1) and Moloney murine leukemia virus (M-MuLV), we evaluated how individual base preferences at a cleavage site direct retroviral RNase H specificity. Strong test cleavage sites (designated as between nucleotide positions -1 and +1) for the HIV-1 and M-MuLV enzymes were introduced into model hybrid substrates designed to assay internal or DNA 3'-end-directed cleavage, and base substitutions were tested at specific nucleotide positions. For internal cleavage, positions +1, -2, -4, -5, -10, and -14 for HIV-1 and positions +1, -2, -6, and -7 for M-MuLV significantly affected RNase H cleavage efficiency, while positions -7 and -12 for HIV-1 and positions -4, -9, and -11 for M-MuLV had more modest effects. DNA 3'-end-directed cleavage was influenced substantially by positions +1, -2, -4, and -5 for HIV-1 and positions +1, -2, -6, and -7 for M-MuLV. Cleavage-site distance from the recessed end did not affect sequence preferences for M-MuLV reverse transcriptase. Based on the identified sequence preferences, a cleavage site recognized by both HIV-1 and M-MuLV enzymes was introduced into a sequence that was otherwise resistant to RNase H. The isolated RNase H domain of M-MuLV reverse transcriptase retained sequence preferences at positions +1 and -2 despite prolific cleavage in the absence of the polymerase domain. The sequence preferences of retroviral RNase H likely reflect structural features in the substrate that favor cleavage and represent a novel specificity determinant to consider in drug design. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20122939      PMCID: PMC2830385          DOI: 10.1016/j.jmb.2010.01.059

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  47 in total

1.  RNA degradation and primer selection by Moloney murine leukemia virus reverse transcriptase contribute to the accuracy of plus strand initiation.

Authors:  C D Kelleher; J J Champoux
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

2.  Analysis of plus-strand primer selection, removal, and reutilization by retroviral reverse transcriptases.

Authors:  S J Schultz; M Zhang; C D Kelleher; J J Champoux
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

3.  Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; Edward Arnold; Stephen H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

4.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

5.  Physical mapping of HIV reverse transcriptase to the 5' end of RNA primers.

Authors:  J J DeStefano; J V Cristofaro; S Derebail; W P Bohlayer; M J Fitzgerald-Heath
Journal:  J Biol Chem       Date:  2001-07-05       Impact factor: 5.157

6.  Sequence, distance, and accessibility are determinants of 5'-end-directed cleavages by retroviral RNases H.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Biol Chem       Date:  2005-11-22       Impact factor: 5.157

7.  Crystal structure of the moloney murine leukemia virus RNase H domain.

Authors:  David Lim; G Glenn Gregorio; Craig Bingman; Erik Martinez-Hackert; Wayne A Hendrickson; Stephen P Goff
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA.

Authors:  S G Sarafianos; K Das; C Tantillo; A D Clark; J Ding; J M Whitcomb; P L Boyer; S H Hughes; E Arnold
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

9.  Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity.

Authors:  Jason W Rausch; Daniela Lener; Jennifer T Miller; John G Julias; Stephen H Hughes; Stuart F J Le Grice
Journal:  Biochemistry       Date:  2002-04-16       Impact factor: 3.162

10.  Combining mutations in HIV-1 reverse transcriptase with mutations in the HIV-1 polypurine tract affects RNase H cleavages involved in PPT utilization.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  Virology       Date:  2006-02-10       Impact factor: 3.616

View more
  10 in total

1.  HIV-1 Reverse Transcriptase Polymerase and RNase H (Ribonuclease H) Active Sites Work Simultaneously and Independently.

Authors:  An Li; Jiawen Li; Kenneth A Johnson
Journal:  J Biol Chem       Date:  2016-10-24       Impact factor: 5.157

2.  RNase H sequence preferences influence antisense oligonucleotide efficiency.

Authors:  Lukasz J Kielpinski; Peter H Hagedorn; Morten Lindow; Jeppe Vinther
Journal:  Nucleic Acids Res       Date:  2017-12-15       Impact factor: 16.971

3.  Structure of HIV-1 reverse transcriptase cleaving RNA in an RNA/DNA hybrid.

Authors:  Lan Tian; Min-Sung Kim; Hongzhi Li; Jimin Wang; Wei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-02       Impact factor: 11.205

4.  Structural and inhibition studies of the RNase H function of xenotropic murine leukemia virus-related virus reverse transcriptase.

Authors:  Karen A Kirby; Bruno Marchand; Yee Tsuey Ong; Tanyaradzwa P Ndongwe; Atsuko Hachiya; Eleftherios Michailidis; Maxwell D Leslie; Daniel V Sietsema; Tracy L Fetterly; Christopher A Dorst; Kamalendra Singh; Zhengqiang Wang; Michael A Parniak; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

5.  Mechanism of polypurine tract primer generation by HIV-1 reverse transcriptase.

Authors:  Małgorzata Figiel; Miroslav Krepl; Sangwoo Park; Jarosław Poznański; Krzysztof Skowronek; Agnieszka Gołąb; Taekjip Ha; Jiří Šponer; Marcin Nowotny
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

6.  Arm-specific cleavage and mutation during reverse transcription of 2΄,5΄-branched RNA by Moloney murine leukemia virus reverse transcriptase.

Authors:  Jessica Döring; Thomas Hurek
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

7.  Development of a ribonuclease containing a G4-specific binding motif for programmable RNA cleavage.

Authors:  Dung Thanh Dang; Anh Tuân Phan
Journal:  Sci Rep       Date:  2019-05-15       Impact factor: 4.379

8.  Large-Scale Photolithographic Synthesis of Chimeric DNA/RNA Hairpin Microarrays To Explore Sequence Specificity Landscapes of RNase HII Cleavage.

Authors:  Jory Lietard; Masad J Damha; Mark M Somoza
Journal:  Biochemistry       Date:  2019-10-28       Impact factor: 3.162

Review 9.  Not making the cut: Techniques to prevent RNA cleavage in structural studies of RNase-RNA complexes.

Authors:  Seth P Jones; Christian Goossen; Sean D Lewis; Annie M Delaney; Michael L Gleghorn
Journal:  J Struct Biol X       Date:  2022-03-11

10.  Structures of HIV-1 RT-RNA/DNA ternary complexes with dATP and nevirapine reveal conformational flexibility of RNA/DNA: insights into requirements for RNase H cleavage.

Authors:  Kalyan Das; Sergio E Martinez; Rajiv P Bandwar; Eddy Arnold
Journal:  Nucleic Acids Res       Date:  2014-05-31       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.